Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00447876
Status:
COMPLETED
Last Update Posted:
2019-11-22
First Post:
2007-03-13
Brief Title:
Study to Assess the Efficacy and Safety of Dysport in the Treatment of Chronic Plantar Fasciitis
Sponsor:
Ipsen
Organization:
Ipsen
Study Overview
Official Title:
Double-blind Placebo-controlled Randomised Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A 200 Units Dysport in the Treatment of Chronic Plantar Fasciitis
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will investigate the hypothesis that the analgesic effect of a single injection of Dysport 200 MU induces a significant reduction of symptoms in chronic cases of plantar fasciitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-002533-39 | EUDRACT_NUMBER | None | None |